In June 2024, the U.S. Pharmacopeial Convention (USP), in collaboration with the Directorate General of Drug Administration (DGDA) and with support from the USAID-funded Promoting the Quality of Medicines Plus (PQM+) program, officially launched the Digitization Roadmap Development initiative for DGDA in Bangladesh. The initiative began with the first Technical Working Group (TWG) meeting, marking a key milestone in the country’s journey toward digital transformation in the pharmaceutical regulatory sector. This project aims to comprehensively assess the existing IT infrastructure and identify gaps within DGDA’s systems. Based on this assessment, a detailed digitization roadmap will be developed to modernize DGDA’s operations and regulatory processes. The ultimate objective is to elevate DGDA to WHO Maturity Level 3, which reflects a well-functioning regulatory system, and to help secure WHO prequalification for the National Drug Control Laboratory (NDCL). This effort will not only strengthen DGDA’s capacity to ensure medicine quality and safety but also contribute to broader public health goals in Bangladesh through improved regulatory efficiency, transparency, and global alignment.
#DGDA #BangladeshHealth #DigitalHealth #PharmaDigitization#USP #USAID #PQMPlus #HealthInnovation #PublicHealth#MaturityLevel3 #WHOStandards #MedicineQuality#NDCL #DigitalTransformation #HealthTech #Pharmaceuticals#HealthcareInnovation #DrugRegulation #StrongerHealthSystems